Monette, A., Warren, S., Barrett, J. C., Garnett-Benson, C., Schalper, K. A., Taube, J. M., Topp, B., Snyder, A.

Therapies targeting the programmed cell death protein-1/programmed death-ligand 1 (PD-L1) (abbreviated as PD-(L)1) axis are a significant advancement in the treatment of many tumor types. However, many patients receiving these agents fail to respond o…